Cite

HARVARD Citation

    Markowitz, M. et al. (2020). Once-Weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques From Intrarectal Challenge With SHIV109CP3. Journal of infectious diseases. pp. 1398-1406. [Online]. 
  
Back to record